在非控制性喘中使用勒布里基祖马布:在一个明确的2型人群中重新分析
Jonathan Corren1, Stanley J Szefler2, Ellen Sher3
1David Geffen School of Medicine at UCLA, Los Angeles, Calif.
The journal of allergy and clinical immunology. In practice
|February 15, 2024
概括
在一组特定的患者中,勒布里奇祖马布显著降低了喘恶化. 这种有针对性的方法改善了高乙酸细胞计数和恶化病史的个体的结果.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 第三期试验 (LAVOLTA I,II,ACOUSTICS) 评估了lebrikizumab,一种IL-13抑制剂,用于不受控制的喘.
- 以前的试验没有证明有效性,可能是由于患者选择标准.
研究的目的:
- 评估lebrikizumab在未经控制的喘患者的定义亚群中的疗效.
- 专注于血中乙氨基酸细胞数量升高和病史有恶化的患者.
主要方法:
- 随机,安慰剂对照试验的lebrikizumab (125毫克或37.5毫克) 或安慰剂,每4周进行一次皮下注射.
- 在患有≥300个细胞/μL起始血红蛋白和≥1个恶化的患者中,对年调整后的恶化率 (AER) 的特设分析.
- 安全性分析包括接受至少一剂lebrikizumab的患者.
主要成果:
- 勒布里奇祖马布在成人和青少年中显著降低了AER,这些青少年具有高胆固醇细胞计数和先前的恶化.
- 观察到的AER降低:成年人为38-41%,青少年为59-64%,取决于剂量.
- 副作用一般为轻度至中度,很少导致治疗中止.
结论:
- 勒布里奇祖马布在一个目标亚群中显著有效地减少了喘恶化.
- 该亚种群的特点是血中乙氨基的升高,FeNO的升高,以及喘恶化的病史.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
298
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
298
Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126


